NATURE . COM {}

Matching Content Categories {📚}

• Telecommunications
• Social Networks
• Photography

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$63,100 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $42,042 to $115,616.

Keywords {🔍}

nature, oncogene, cancer, article, access, cell, content, cooperation, carnero, res, cookies, cmyc, oncogenic, privacy, senescence, beach, ras, eilers, weinberg, serrano, research, data, journal, absence, pwaf, rasinduced, myc, open, land, embo, genes, dev, advertising, information, subscribe, amancio, pnull, pik, institution, buy, author, permissions, optional, media, personal, parties, policy, journals, log, short,

Topics {✒️}

nature portfolio permissions reprints privacy policy c-myc-overexpressing p21-null cells biomedical research advertising social media nature bypassing ras-induced senescence author information authors trigger ros-induced autophagy author correspondence myc+ras increased cooperatively personal data p53 tumor suppressor ras-induced inhibition springerlink instant access data protection permissions enhances oncogenic cooperation p21-null cells cell growth differ increased oncogenic cooperation c-myc transduction privacy p21-null background oncogenic ras expression issue learn explore content subscription content ministerio de ciencia article carnero european economic area mouse embryo fibroblasts institutional subscriptions read munoz-alonso mj von der lehr catherine stevenson chair accepting optional cookies journals search log cellular immortalization lead c-myc franza jr br amancio carnero nucleic acids res cellular senescence manage preferences https oncogenic cooperation cancer cell proliferation

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation
         description:The absence of p21waf1 combined with an ectopic expression of c-myc prevents ras-induced senescence in mouse embryo fibroblasts. Extension of lifespan after c-myc transduction into p21-null cells was followed at later passages by apoptosis of a large fraction of c-myc-overexpressing p21-null cells. This apoptotic effect could be overridden by inactivation of the p53 tumor suppressor or oncogenic ras expression. Ras-induced inhibition of apoptosis is mediated by PI3K activation. These results suggest a functional relationship between ras and myc that may explain their oncogenic cooperation. The number of foci formed by myc+ras increased cooperatively in the absence of p21waf1. Thus, the reciprocal cooperation between myc and ras in a p21-null background during cellular immortalization lead to increased oncogenic cooperation between ras and myc.
         datePublished:2004-06-14T00:00:00Z
         dateModified:2004-06-14T00:00:00Z
         pageStart:6006
         pageEnd:6011
         sameAs:https://doi.org/10.1038/sj.onc.1207839
         keywords:
            oncogenic cooperation
            c-myc
             ras
            waf1
            PI3k
            Medicine/Public Health
            general
            Internal Medicine
            Cell Biology
            Human Genetics
            Oncology
            Apoptosis
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1207839/MediaObjects/41388_2004_Article_BF1207839_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1207839/MediaObjects/41388_2004_Article_BF1207839_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1207839/MediaObjects/41388_2004_Article_BF1207839_Fig3_HTML.jpg
         isPartOf:
            name:Oncogene
            issn:
               1476-5594
               0950-9232
            volumeNumber:23
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Amancio Carnero
               affiliation:
                     name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO)
                     address:
                        name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:David H Beach
               affiliation:
                     name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building
                     address:
                        name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation
      description:The absence of p21waf1 combined with an ectopic expression of c-myc prevents ras-induced senescence in mouse embryo fibroblasts. Extension of lifespan after c-myc transduction into p21-null cells was followed at later passages by apoptosis of a large fraction of c-myc-overexpressing p21-null cells. This apoptotic effect could be overridden by inactivation of the p53 tumor suppressor or oncogenic ras expression. Ras-induced inhibition of apoptosis is mediated by PI3K activation. These results suggest a functional relationship between ras and myc that may explain their oncogenic cooperation. The number of foci formed by myc+ras increased cooperatively in the absence of p21waf1. Thus, the reciprocal cooperation between myc and ras in a p21-null background during cellular immortalization lead to increased oncogenic cooperation between ras and myc.
      datePublished:2004-06-14T00:00:00Z
      dateModified:2004-06-14T00:00:00Z
      pageStart:6006
      pageEnd:6011
      sameAs:https://doi.org/10.1038/sj.onc.1207839
      keywords:
         oncogenic cooperation
         c-myc
          ras
         waf1
         PI3k
         Medicine/Public Health
         general
         Internal Medicine
         Cell Biology
         Human Genetics
         Oncology
         Apoptosis
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1207839/MediaObjects/41388_2004_Article_BF1207839_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1207839/MediaObjects/41388_2004_Article_BF1207839_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1207839/MediaObjects/41388_2004_Article_BF1207839_Fig3_HTML.jpg
      isPartOf:
         name:Oncogene
         issn:
            1476-5594
            0950-9232
         volumeNumber:23
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Amancio Carnero
            affiliation:
                  name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO)
                  address:
                     name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:David H Beach
            affiliation:
                  name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building
                  address:
                     name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Oncogene
      issn:
         1476-5594
         0950-9232
      volumeNumber:23
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO)
      address:
         name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
         type:PostalAddress
      name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building
      address:
         name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building, London, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Amancio Carnero
      affiliation:
            name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO)
            address:
               name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:David H Beach
      affiliation:
            name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building
            address:
               name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building, London, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
      name:Wolfson Institute for Biomedical Research, UCL, Cruciform Building, London, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(1)

• https://twitter.com/oncogenejournal

External Links {🔗}(17)

• How much does https://link.springer.com/article/10.1038/sj.onc.1207839?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle earn?
• Earnings of https://citation-needed.springer.com/v2/references/10.1038/sj.onc.1207839?format=refman&flavour=references
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Amancio%20Carnero's revenue stream
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Amancio%20Carnero%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=David%20H%20Beach
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22David%20H%20Beach%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://s100.copyright.com/AppDispatchServlet?title=Absence%20of%20p21WAF1%20cooperates%20with%20c-myc%20in%20bypassing%20Ras-induced%20senescence%20and%20enhances%20oncogenic%20cooperation&author=Amancio%20Carnero%20et%20al&contentID=10.1038%2Fsj.onc.1207839©right=Springer%20Nature%20Limited&publication=0950-9232&publicationDate=2004-06-14&publisherName=SpringerNature&orderBeanReset=true make?
• Get to know what's the income of https://citation-needed.springer.com/v2/references/10.1038/sj.onc.1207839?format=refman&flavour=citation
• How much revenue does https://doi.org/10.1038/s41416-022-01755-0 produce monthly?
• Monthly income for https://doi.org/10.1038/onc.2011.619
• How much profit does https://doi.org/10.1007/s00109-010-0701-7 make?
• How much does https://doi.org/10.1038/nrc2657 generate monthly?
• What's the financial gain of https://doi.org/10.1007/s12094-009-0407-x?
• How much does https://www.protocols.io/ net monthly?
• https://www.natureindex.com/ income
• What's the monthly income of http://www.naturechina.com?
• How much revenue does https://www.natureasia.com/ja-jp generate?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk